Vimarsana
Biggest News Aggregation in the World

Page 27 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

15 Cash-Rich Penny Stocks Hedge Funds Are Buying - Vimarsana News

15 Cash-Rich Penny Stocks Hedge Funds Are Buying

In this article, we will take a detailed look at the 15 Cash-Rich Penny Stocks Hedge Funds Are Buying. For a quick overview of such stocks, read our article 5 Cash-Rich Penny Stocks Hedge Funds Are Buying. Risky asset classes got punished after the Federal Reserve started to raise interest rates to tackle inflation. But amid the talk of […]

Source: yahoo.com
Short Interest in Ascletis Pharma Inc. (OTCMKTS:ASCLF) Decreases By 92.4% - Vimarsana News

Short Interest in Ascletis Pharma Inc. (OTCMKTS:ASCLF) Decreases By 92.4%

Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) was the recipient of a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 53,800 shares, a decrease of 92.4% from the December 31st total of 706,000 shares. Based on an average daily trading volume, of 2,900 […]

FSD Pharma Inc. (NASDAQ:HUGE) Shares Sold by AdvisorShares Investments LLC - Vimarsana News

FSD Pharma Inc. (NASDAQ:HUGE) Shares Sold by AdvisorShares Investments LLC

AdvisorShares Investments LLC cut its holdings in shares of FSD Pharma Inc. (NASDAQ:HUGE – Free Report) by 5.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 235,637 shares of the company’s stock after selling 13,668 shares during the period. AdvisorShares Investments LLC owned […]

What's Going On With ESSA Pharma Stock Today? - ESSA Pharma (NASDAQ:EPIX) - Vimarsana News

What's Going On With ESSA Pharma Stock Today? - ESSA Pharma (NASDAQ:EPIX)

ESSA Pharma shares fell 22.6% at $6.80 yesterday. Explore masofaniten's promising Phase 1/2 results in prostate cancer treatment. Updated data, PSA reductions, and financial strength.

What's Going On With Prostate Cancer Focused ESSA Pharma Stock Today? - Vimarsana News

What's Going On With Prostate Cancer Focused ESSA Pharma Stock Today?

Thursday, ESSA Pharma Inc EPIX shares closed 22.6% lower at $6.80. According to data from Benzinga Pro, session volume stands at 447.615K compared to the…

Source: biztoc.com